Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma

被引：0
|
作者：
P. G. Corrie
W. Qian
B. Basu
J. W. Valle
S. Falk
C. lwuji
H. Wasan
D. Palmer
M. Scott-Brown
J. Wadsley
S. Arif
J. Bridgewater
D. Propper
R. Gillmore
A. Gopinathan
R. Skells
P. Bundi
R. Brais
K. Dalchau
L. Bax
A. Chhabra
A. Machin
A. Dayim
K. McAdam
S. Cummins
L. Wall
R. Ellis
A. Anthoney
J. Evans
Y. T. Ma
C. Isherwood
A. Neesse
D. Tuveson
D. I. Jodrell
机构：
[1] Cambridge University Hospitals NHS Foundation Trust (Addenbrooke’s Hospital),Gastroenterology and Gastrointestinal Cancer Clinic
[2] Cancer Research UK—Cambridge Institute,undefined
[3] University of Cambridge,undefined
[4] University of Manchester and The Christie NHS Foundation Trust,undefined
[5] Bristol Haematology and Oncology Centre,undefined
[6] Leicester Royal Infirmary,undefined
[7] Hammersmith Hospital,undefined
[8] Imperial College,undefined
[9] Clatterbridge Cancer Centre,undefined
[10] University Hospital Coventry and Warwickshire,undefined
[11] Weston Park Hospital,undefined
[12] Velindre Cancer Centre,undefined
[13] UCL Cancer Institute,undefined
[14] Barts Cancer Institute,undefined
[15] The Royal Free Hospital,undefined
[16] Peterborough City Hospital,undefined
[17] Royal Surrey County Hospital,undefined
[18] Western General Hospital,undefined
[19] Royal Cornwall Hospitals,undefined
[20] St. James’s University Hospitals,undefined
[21] Beatson West of Scotland Cancer Centre,undefined
[22] University of Glasgow,undefined
[23] Queen Elizabeth Hospital,undefined
[24] University of Göttingen,undefined
[25] Cold Spring Harbor Laboratory,undefined
来源：
British Journal of Cancer | 2020年 / 122卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1760 / 1768
页数：8
相关论文
共 50 条
  • [31] First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?
    Vivaldi, Caterina
    Salani, Francesca
    Rovesti, Giulia
    Pecora, Irene
    Catanese, Silvia
    Casadei-Gardini, Andrea
    Massa, Valentina
    Bernardini, Laura
    Riggi, Laura
    Andrikou, Kalliopi
    Rapposelli, Giovanni I.
    Formica, Vincenzo
    Lencioni, Monica
    Falcone, Alfredo
    Vasile, Enrico
    Fornaro, Lorenzo
    EUROPEAN JOURNAL OF CANCER, 2020, 137 : 108 - 116
  • [32] Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine
    Di Costanzo, Francesco
    Di Costanzo, Federica
    Antonuzzo, Lorenzo
    Mazza, Ernesto
    Giommoni, Elisa
    CANCERS, 2023, 15 (02)
  • [33] The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective study
    Lei Yang
    Jing Su
    Wenbo Wang
    Fuxiang Zhou
    World Journal of Surgical Oncology, 21
  • [34] Efficacy and Safety of Nab-Paclitaxel Plus S-1 versus Nab-Paclitaxel Plus Gemcitabine for First-Line Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma
    Zong, Yuan
    Peng, Zhi
    Wang, Xicheng
    Lu, Ming
    Shen, Lin
    Zhou, Jun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12657 - 12666
  • [35] Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma A Phase 2 Clinical Trial
    Sahai, Vaibhav
    Catalano, Paul J.
    Zalupski, Mark M.
    Lubner, Sam Joseph
    Menge, Mark R.
    Nimeiri, Halla Sayed
    Munshi, Hidayatullah G.
    Benson, Al Bowen, III
    O'Dwyer, Peter J.
    JAMA ONCOLOGY, 2018, 4 (12) : 1707 - 1712
  • [36] The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective study
    Yang, Lei
    Su, Jing
    Wang, Wenbo
    Zhou, Fuxiang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [37] A phase Ib study evaluating olaratumab in combination with nab-paclitaxel and gemcitabine in first-line treatment of metastatic pancreatic cancer.
    Pelzer, Uwe
    Bendell, Johanna C.
    Womack, Mark S.
    Bahary, Nathan
    Macarulla, Teresa
    Borazanci, Erkut Hasan
    Levy, Donna Elise
    Mo, Gary
    Ramage, Samuel Cowan
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [38] Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer
    Petrioli, Roberto
    Torre, Pamela
    Pesola, Guido
    Paganini, Giovanni
    Paolelli, Loretta
    Miano, Salvatora Tindara
    Martellucci, Ignazio
    Francini, Guido
    Francini, Edoardo
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (04) : 647 - 651
  • [39] Toripalimab combined with nab-paclitaxel/gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma: Updated results of a phase Ib/II clinical study.
    Cheng, Ke
    Lv, Wanrui
    Li, Xiaofen
    Chang, Chen
    Cao, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16244 - E16244
  • [40] Pancreatic enzyme replacement therapy improves survival in patients receiving nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma
    Lavacchi, D.
    Winchler, C.
    Giommoni, E.
    Vascotto, I. A.
    Romano, S.
    Scolari, F.
    Taddei, A.
    Pillozzi, S.
    Galli, A.
    Antonuzzo, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S920 - S920
12345